Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Cash Inflow / Outflow

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Cash Inflow / Outflow ₹-63 Cr₹63 Cr₹0.58 Cr₹-2.45 Cr₹0.83 Cr

What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) is ₹-63 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-63 Cr
Mar2024₹63 Cr
Mar2023₹0.58 Cr
Mar2022₹-2.45 Cr
Mar2017₹0.83 Cr

How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-63 Cr
Negative
Mar2024 ₹63 Cr
10,713.84
Mar2023 ₹0.58 Cr
Positive
Mar2022 ₹-2.45 Cr
Negative
Mar2017 ₹0.83 Cr -

Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,349.8 Cr 2.2% 9.4% -20.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2.2%

9.4%

-20.4%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses